Anebulo Pharmaceuticals Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Anebulo Pharmaceuticals.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Pharmaceuticals earnings growth | 23.7% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 18 Nov 2024 |
Recent future growth updates
Recent updates
Here's Why We're Watching Anebulo Pharmaceuticals' (NASDAQ:ANEB) Cash Burn Situation
Jun 22
Is Anebulo Pharmaceuticals (NASDAQ:ANEB) In A Good Position To Deliver On Growth Plans?
Feb 18Is Anebulo Pharmaceuticals (NASDAQ:ANEB) In A Good Position To Invest In Growth?
Jul 03Companies Like Anebulo Pharmaceuticals (NASDAQ:ANEB) Are In A Position To Invest In Growth
Mar 07We Think Anebulo Pharmaceuticals (NASDAQ:ANEB) Can Afford To Drive Business Growth
Nov 19Anebulo Pharmaceuticals to launch private investment in public equity financing
Sep 26Anebulo Pharmaceuticals GAAP EPS of -$0.10 misses by $0.03
Sep 09Here's Why We're Not Too Worried About Anebulo Pharmaceuticals' (NASDAQ:ANEB) Cash Burn Situation
Jun 28Companies Like Anebulo Pharmaceuticals (NASDAQ:ANEB) Are In A Position To Invest In Growth
Mar 15Here's Why We're Not Too Worried About Anebulo Pharmaceuticals' (NASDAQ:ANEB) Cash Burn Situation
Nov 04Anebulo Pharmaceuticals reports FQ3 results
Jun 21In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Anebulo Pharmaceuticals has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 6/30/2025 | N/A | -9 | N/A | N/A | 1 |
| 9/30/2024 | N/A | -8 | -7 | -7 | N/A |
| 6/30/2024 | N/A | -8 | -8 | -8 | N/A |
| 3/31/2024 | N/A | -9 | -9 | -9 | N/A |
| 12/31/2023 | N/A | -10 | -10 | -10 | N/A |
| 9/30/2023 | N/A | -12 | -10 | -10 | N/A |
| 6/30/2023 | N/A | -12 | -10 | -10 | N/A |
| 3/31/2023 | N/A | -12 | -9 | -9 | N/A |
| 12/31/2022 | N/A | -11 | -8 | -8 | N/A |
| 9/30/2022 | N/A | -8 | -7 | -7 | N/A |
| 6/30/2022 | N/A | -7 | -5 | -5 | N/A |
| 3/31/2022 | N/A | -34 | -7 | -7 | N/A |
| 12/31/2021 | N/A | -41 | -6 | -6 | N/A |
| 9/30/2021 | N/A | -40 | -6 | -6 | N/A |
| 6/30/2021 | N/A | -38 | -5 | -5 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if ANEB's forecast earnings growth is above the savings rate (2.6%).
Earnings vs Market: Insufficient data to determine if ANEB's earnings are forecast to grow faster than the US market
High Growth Earnings: Insufficient data to determine if ANEB's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if ANEB's revenue is forecast to grow faster than the US market.
High Growth Revenue: Insufficient data to determine if ANEB's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if ANEB's Return on Equity is forecast to be high in 3 years time